Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women

Neurology

Volumn 57, Issue 12, 2001, Pages 2223-2228

  Cohen, R M ^a,b   Small, C ^a   Lalonde, F ^a   Friz, J ^a   Sunderland, T ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALLELE; ARTICLE; BRAIN SIZE; BRAIN SLICE; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; MEMORY; PRIORITY JOURNAL;

EID: 0035956552     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.12.2223     Document Type: Article

References (50)

1. Neuroimaging with CT and MRI in Alzheimer disease
2. Apolipoprotein E alleles as risk factors in Alzheimer's disease
3. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
4. Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
5. Apolipoprotein E phenotype and cognitive decline in a perspective study of elderly community women
6. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling individuals with and without dementia
7. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype
8. Apolipoprotein E and cognitive change in an elderly population
9. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease
10. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease
11. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
12. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women
13. The earliest cognitive change in a person with familial Alzheimer's disease: Presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy
14. Neuropsychological features of memory disorders in Alzheimer disease
15. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation
16. Observations on the brains of demented old people
17. Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults
18. Selective reminding for analysis of memory and learning
19. Word fluency and brain damage
20. Dementia rating scale
21. Localization of cerebral lesions by psychological testing
22. Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR-RFLP fragments
23. Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
24. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome
25. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease
26. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
27. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions
28. Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI
29. Memory and MRI-based hippocampal volumes in aging and AD
30. Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type
31. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment
32. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type
33. Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type
34. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease
35. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
36. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
37. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease
38. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
39. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease
40. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
41. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls)
42. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD
43. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
44. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD
45. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele
46. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease
47. Apolipoprotein E4: An allele associated with many diseases